Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-797-4 | CAS number: 91893-72-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-06-14 to 2018-08-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 30 May 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- potassium 2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)ethane-1-sulfonate
- EC Number:
- 618-797-4
- Cas Number:
- 91893-72-0
- Molecular formula:
- C10H9NO5S.K
- IUPAC Name:
- potassium 2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)ethane-1-sulfonate
- Test material form:
- solid: particulate/powder
Constituent 1
Method
- Target gene:
- histidine locus
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix (rat liver)
- Test concentrations with justification for top dose:
- 31.6, 100, 316, 1000, 3160, 5000 µg/plate; the results of a preliminary test revealed no cytotoxicity up to the top dose of 5000 µg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: highly purified water
- Justification for choice of solvent/vehicle: Solubility of the test item
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- mitomycin C
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) and preincubation
- Cell density at seeding (if applicable): 1E+08 - 1E+09 cells/mL
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 per concentration and/or control in 2 independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: reduction in the number of spontaneous revertants by at least 50%, a clearing or dimunition of the background lawn or by the degree of survival of the treated cultures - Rationale for test conditions:
- As recommended by the test guideline
- Evaluation criteria:
- A test item is considered to show a positive response if
- the number of revertants is significantly increased (p ≤ 0.05, U-test according to MANN and WHITNEY) compared to the solvent control to at least 2-fold of the solvent control for TA98, TA100, TA1535 and TA1537 and 1.5-fold of the solvent control for TA102 in both independent experiments.
- a concentration-related increase over the range tested in the number of the revertants per plate is observed. The Spearman's rank correlation coefficient may be applied.
- Biological relevance of the results should be considered first.
Positive results from the bacterial reverse mutation test indicate that a substance induces point mutations by base substitutions or frameshifts in the genome of Salmonella typhimurium. A test item for which the results do not meet the above mentioned criteria is considered as non-mutagenic in the AMES test. - Statistics:
- U-test according to MANN and WHITNEY and the Spearman's rank correlation coefficient
Results and discussion
Test results
- Key result
- Species / strain:
- S. typhimurium, other: TA98, TA100, TA102, TA1535 and TA1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not reported
- Effects of osmolality: Not reported
- Evaporation from medium: Not reported
- Water solubility: 93 g/L
- Precipitation: Not reported
RANGE-FINDING/SCREENING STUDIES: A preliminary (plate incorporation test, without and with metabolic activation) with the tester strain TA100 revealed not cytotoxicity up to the top dose of 5000 µg/plate
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: see ' Any other information on results incl. tables'
- Negative (solvent/vehicle) historical control data: see ' Any other information on results incl. tables'
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: reduction in the number of spontaneous revertants by at least 50%, a clearing or dimunition of the background lawn or by the degree of survival of the treated cultures
Any other information on results incl. tables
Tables 1 & 2: History profile of Negative and Positive Control Values of three years (n=88), Data obtained from plate incorporation and preincubation tests
Negative Reference item
Strain
|
TA98 |
TA100 |
TA102 |
TA1535 |
TA1537 |
|||||
S9-Mix |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
Mean |
30.2 |
31.9 |
145.9 |
145.1 |
278.1 |
279.0 |
19.7 |
19.9 |
6.7 |
6.7 |
SD |
5.6 |
5.9 |
19.6 |
19.9 |
16.9 |
17.5 |
4.4 |
4.6 |
1.8 |
1.8 |
Min |
20 |
20 |
95 |
100 |
245 |
203 |
10 |
10 |
2 |
2 |
Max |
49 |
49 |
200 |
209 |
323 |
324 |
34 |
36 |
10 |
10 |
Positive Reference item
Strain
|
TA98 |
TA100 |
TA102 |
TA1535 |
TA1537 |
|||||
S9-Mix |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
2-nitro-fluorene |
Benzo[a] pyrene |
sodium azide |
2-amino-anthracene |
Mitomycin C |
Benzo[a] pyrene |
sodium azide |
2-amino-anthracene |
9-amino-acridine |
Benzo[a] pyrene |
Mean |
158.8 |
157.6 |
954.0 |
949.5 |
1020.7 |
1015.0 |
144.5 |
144.5 |
75.0 |
75.9 |
SD |
26.2 |
26.9 |
102.1 |
104.3 |
90.8 |
95.1 |
44.7 |
47.4 |
26.9 |
26.4 |
Min |
102 |
104 |
701 |
703 |
756 |
759 |
62 |
67 |
28 |
31 |
Max |
293 |
291 |
1365 |
1238 |
1263 |
1311 |
406 |
404 |
185 |
184 |
Tables 3 -6: Summarized data from the plate incorporation and preincubation tests (with and without metabolic activation)
Test item (µg/plate) |
|
Plate incorporation test without metabolic activation |
||||
|
|
Number of revertant colonies |
||||
|
|
TA-98 |
TA-100 |
TA-102 |
TA-1535 |
TA-1537 |
|
|
Mean values±SD |
||||
TA-1 |
|
|
|
|
|
|
31.6 |
mean |
25.3 |
160.0 |
255.3 |
17.7 |
8.0 |
|
SD |
2.5 |
1.0 |
4.6 |
1.2 |
1.7 |
100 |
mean |
28.0 |
149.3 |
252.7 |
16.7 |
6.0 |
|
SD |
0.0 |
12.2 |
3.1 |
2.3 |
1.0 |
316 |
mean |
30.3 |
166.3 |
269.3 |
24.0 |
6.7 |
|
SD |
7.1 |
13.7 |
9.9 |
4.4 |
1.5 |
1000 |
mean |
27.3 |
162.7 |
287.0 |
16.3 |
9.3 |
|
SD |
2.1 |
9.0 |
8.2 |
4.0 |
0.6 |
3160 |
mean |
26.0 |
171.0 |
264.0 |
19.7 |
4.7 |
|
SD |
1.0 |
7.9 |
15.7 |
0.6 |
1.2 |
5000 |
mean |
28.0 |
125.3 |
265.3 |
21.3 |
6.0 |
|
SD |
7.8 |
0.6 |
5.9 |
4.2 |
0.0 |
Negative reference item 100µL/plate) |
mean |
28.7 |
188.0 |
283.7 |
25.0 |
5.3 |
|
SD |
3.2 |
4.4 |
5.0 |
3.6 |
2.1 |
Positive reference item |
|
2-Nitrofluorene |
Sodium azide |
Mitomycin C |
Sodium azide |
9-Amino-acridine |
Concentration [µg/plate] |
|
10 |
10 |
10 |
10 |
100 |
|
mean |
181.7 |
1105.3 |
1100.3 |
174.3 |
52.0 |
|
SD |
15.0 |
86.4 |
29.9 |
3.2 |
16.5 |
Test item (µg/plate) |
|
Plate incorporation test with metabolic activation |
||||
|
|
Number of revertant colonies |
||||
|
|
TA-98 |
TA-100 |
TA-102 |
TA-1535 |
TA-1537 |
|
|
Mean values±SD |
||||
TA-1 |
|
|
|
|
|
|
31.6 |
mean |
28.7 |
172.0 |
270.0 |
17.7 |
6.7 |
|
SD |
0.6 |
14.8 |
4.0 |
2.1 |
0.6 |
100 |
mean |
31.3 |
163.7 |
261.3 |
16.3 |
6.3 |
|
SD |
5.8 |
9.1 |
2.1 |
0.6 |
0.6 |
316 |
mean |
24.3 |
173.3 |
270.7 |
22.7 |
7.0 |
|
SD |
3.2 |
9.1 |
1.2 |
0.6 |
0.0 |
1000 |
mean |
34.7 |
167.3 |
271.7 |
24.0 |
4.3 |
|
SD |
2.5 |
15.3 |
10.1 |
3.5 |
2.3 |
3160 |
mean |
32.3 |
174.3 |
273.0 |
19.7 |
6.3 |
|
SD |
4.6 |
0.6 |
16.5 |
5.1 |
0.6 |
5000 |
mean |
27.7 |
185.7 |
272.0 |
17.0 |
3.3 |
|
SD |
0.6 |
2.1 |
9.2 |
5.3 |
0.6 |
Negative reference item 100µL/plate) |
mean |
32.7 |
175.3 |
276.7 |
22.7 |
4.7 |
|
SD |
6.0 |
2.5 |
14.4 |
3.2 |
1.2 |
Positive reference item |
|
Benzo[a] pyrene |
2-Amino-anthracene |
Benzo[a] pyrene |
2-Amino-anthracene |
Benzo[a] pyrene |
Concentration [µg/plate] |
|
10 |
2 |
10 |
2 |
10 |
|
mean |
178.3 |
1129.7 |
1101.3 |
156.7 |
60.7 |
|
SD |
5.5 |
91.6 |
9.5 |
35.4 |
18.8 |
Test item (µg/plate) |
|
Preincubation test without metabolic activation |
||||
|
|
Number of revertant colonies |
||||
|
|
TA-98 |
TA-100 |
TA-102 |
TA-1535 |
TA-1537 |
|
|
Mean values±SD |
||||
TA-1 |
|
|
|
|
|
|
31.6 |
mean |
37.7 |
185.3 |
283.3 |
20.3 |
5.7 |
|
SD |
1.5 |
4.9 |
0.6 |
2.1 |
2.3 |
100 |
mean |
26.0 |
184.7 |
290.0 |
17.7 |
7.7 |
|
SD |
0.0 |
5.5 |
7.5 |
7.4 |
2.5 |
316 |
mean |
34.3 |
177.7 |
277.3 |
22.0 |
4.7 |
|
SD |
6.4 |
4.2 |
28.1 |
3.6 |
1.2 |
1000 |
mean |
38.3 |
171.3 |
271.0 |
19.0 |
4.3 |
|
SD |
3.5 |
0.6 |
1.7 |
2.6 |
0.6 |
3160 |
mean |
27.3 |
178.0 |
269.7 |
23.0 |
4.3 |
|
SD |
2.5 |
12.1 |
22.1 |
3.6 |
1.5 |
5000 |
mean |
30.7 |
178.3 |
249.7 |
26.0 |
6.0 |
|
SD |
4.0 |
21.4 |
5.7 |
1.0 |
1.0 |
Negative reference item 100µL/plate) |
mean |
34.3 |
189.0 |
284.3 |
22.0 |
6.0 |
5.1 |
SD |
6.8 |
3.6 |
5.1 |
1.0 |
1.0 |
Positive reference item |
|
2-Nitro-fluorene |
Sodium azide |
Mitomycin C |
Sodium azide |
9-Amino-acridine |
Concentration [µg/plate] |
|
10 |
10 |
10 |
10 |
100 |
|
mean |
150.0 |
932.7 |
1019.7 |
119.0 |
32.3 |
|
SD |
13.9 |
88.5 |
40.3 |
7.5 |
0.6 |
Test item (µg/plate) |
|
Preincubation test without metabolic activation |
||||
|
|
Number of revertant colonies |
||||
|
|
TA-98 |
TA-100 |
TA-102 |
TA-1535 |
TA-1537 |
|
|
Mean values±SD |
||||
TA-1 |
|
|
|
|
|
|
31.6 |
mean |
30.0 |
182.7 |
283.0 |
15.3 |
5.7 |
|
SD |
3.5 |
9.3 |
7.9 |
2.3 |
0.6 |
100 |
mean |
35.0 |
165.3 |
275.7 |
14.7 |
5.7 |
|
SD |
5.2 |
23.7 |
24.5 |
0.6 |
0.6 |
316 |
mean |
33.3 |
169.3 |
277.7 |
14.3 |
5.3 |
|
SD |
6.7 |
0.6 |
7.8 |
1.5 |
1.2 |
1000 |
mean |
31.7 |
165.3 |
269.3 |
18.3 |
3.7 |
|
SD |
1.2 |
12.4 |
3.1 |
2.5 |
0.6 |
3160 |
mean |
34.0 |
148.7 |
259.0 |
14.3 |
5.0 |
|
SD |
1.0 |
17.6 |
6.6 |
2.3 |
1.0 |
5000 |
mean |
35.7 |
149.7 |
280.0 |
15.0 |
4.0 |
|
SD |
1.5 |
26.9 |
10.0 |
1.0 |
1.7 |
Negative reference item 100µL/plate) |
mean |
39.0 |
189.0 |
287.3 |
15.0 |
5.7 |
|
SD |
2.6 |
15.6 |
9.0 |
4.4 |
1.2 |
Positive reference item |
|
2-Nitro-fluorene |
Sodium azide |
Mitomycin C |
Sodium azide |
9-Amino-acridine |
Concentration [µg/plate] |
|
10 |
10 |
10 |
10 |
100 |
|
mean |
135.7 |
944.0 |
980.7 |
121.7 |
61.7 |
|
SD |
20.3 |
100.5 |
60.5 |
3.5 |
22.3 |
Applicant's summary and conclusion
- Conclusions:
- In conclusion, under the present test conditions, the test item tested up to the top concentration of 5000 µg/plate caused no mutagenic effect in the Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 neither in the plate incorporation test nor in the preincubation test each carried out without and with metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
